These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 38411300)
1. Lacosamide and pregnancy: Data from spontaneous and solicited reports. Perucca P; Bourikas D; Voinescu PE; Vadlamudi L; Chellun D; Kumke T; Werhahn KJ; Schmitz B Epilepsia; 2024 May; 65(5):1275-1284. PubMed ID: 38411300 [TBL] [Abstract][Full Text] [Related]
2. Preliminary results on pregnancy outcomes in women using lamotrigine. Tennis P; Eldridge RR; Epilepsia; 2002 Oct; 43(10):1161-7. PubMed ID: 12366730 [TBL] [Abstract][Full Text] [Related]
3. Comparing the General Practice Research Database and the UK Epilepsy and Pregnancy Register as tools for postmarketing teratogen surveillance: anticonvulsants and the risk of major congenital malformations. Charlton RA; Weil JG; Cunnington MC; Ray S; de Vries CS Drug Saf; 2011 Feb; 34(2):157-71. PubMed ID: 21247222 [TBL] [Abstract][Full Text] [Related]
4. Outcomes following exposure to lacosamide monotherapy during pregnancy and breastfeeding - a prospective case series. Bosak M; Dziedzic R; Matwiej K; Słowik A Neurol Neurochir Pol; 2024; 58(2):203-206. PubMed ID: 38305480 [TBL] [Abstract][Full Text] [Related]
5. Malformation risk of antiepileptic drug exposure during pregnancy in women with epilepsy: Results from a pregnancy registry in South India. Thomas SV; Jose M; Divakaran S; Sankara Sarma P Epilepsia; 2017 Feb; 58(2):274-281. PubMed ID: 28084641 [TBL] [Abstract][Full Text] [Related]
6. Pregnancy Outcomes After Exposure to Certolizumab Pegol: Updated Results From a Pharmacovigilance Safety Database. Clowse MEB; Scheuerle AE; Chambers C; Afzali A; Kimball AB; Cush JJ; Cooney M; Shaughnessy L; Vanderkelen M; Förger F Arthritis Rheumatol; 2018 Sep; 70(9):1399-1407. PubMed ID: 29623679 [TBL] [Abstract][Full Text] [Related]
7. Maternal and fetal outcomes of antiepileptic treatments during pregnancy: A retrospective study. Zeytin Demiral G; Betaş Akın S; Kayacık Günday Ö; Şahbaz FG; Türk Börü Ü Epilepsy Behav; 2024 Sep; 158():109937. PubMed ID: 39002279 [TBL] [Abstract][Full Text] [Related]
8. A prospective, multicenter, noninterventional study in Taiwan to evaluate the safety and tolerability of lacosamide as adjunctive therapy for epilepsy in clinical practice. Wu T; Chuang YC; Huang HC; Lim SN; Hsieh PF; Lee WT; Cheng MY; Tsai MH; Jou SB; Chang CW; Hsieh HY; Du X; Hellot S; McClung C; Hung C Epilepsy Behav; 2020 Dec; 113():107464. PubMed ID: 33152580 [TBL] [Abstract][Full Text] [Related]
9. Fetal effects of anticonvulsant polytherapies: different risks from different drug combinations. Holmes LB; Mittendorf R; Shen A; Smith CR; Hernandez-Diaz S Arch Neurol; 2011 Oct; 68(10):1275-81. PubMed ID: 21670385 [TBL] [Abstract][Full Text] [Related]
10. The challenges of assessing effectiveness of lacosamide using electronic medical record databases. Kalilani L; Halpern R; Seare J; Dedeken P Epilepsy Behav; 2018 Aug; 85():195-199. PubMed ID: 30032807 [TBL] [Abstract][Full Text] [Related]
11. Quality of life, mood and seizure control in patients with brain tumor related epilepsy treated with lacosamide as add-on therapy: A prospective explorative study with a historical control group. Maschio M; Zarabla A; Maialetti A; Fabi A; Vidiri A; Villani V; Giannarelli D Epilepsy Behav; 2017 Aug; 73():83-89. PubMed ID: 28623754 [TBL] [Abstract][Full Text] [Related]
12. Effectiveness and safety of Lacosamide in pediatric patients with epilepsy under four years: Results from a prospective cohort study in China. Xiong L; He H; Wang D; Liu T; Xiao N Seizure; 2024 May; 118():71-79. PubMed ID: 38643678 [TBL] [Abstract][Full Text] [Related]
13. Increasing use of newer antiseizure medication during pregnancy: An observational study with special focus on lacosamide. Hoeltzenbein M; Slimi S; Fietz AK; Stegherr R; Onken M; Beyersmann J; Dathe K; Schaefer C Seizure; 2023 Apr; 107():107-113. PubMed ID: 37003184 [TBL] [Abstract][Full Text] [Related]
14. The teratogenic risk of antiepileptic drug polytherapy. Vajda FJ; Hitchcock AA; Graham J; O'Brien TJ; Lander CM; Eadie MJ Epilepsia; 2010 May; 51(5):805-10. PubMed ID: 19817810 [TBL] [Abstract][Full Text] [Related]
15. Prevalence of epilepsy in Saudi pregnant women and possible effects of anti-epileptic drugs on pregnancy outcomes. AlSheikh MH Neurosciences (Riyadh); 2020 Jan; 25(1):32-37. PubMed ID: 31982897 [TBL] [Abstract][Full Text] [Related]
16. Do Anti-Epileptic Drug modifications after first trimester of pregnancy influence fetal malformation or cognitive outcome? Asranna A; Jose M; Philip RM; Sarma PS; Thomas SV Epilepsy Res; 2018 Oct; 146():121-125. PubMed ID: 30098567 [TBL] [Abstract][Full Text] [Related]
17. Antiepileptic drug use during pregnancy: perinatal outcomes. Kulaga S; Sheehy O; Zargarzadeh AH; Moussally K; Bérard A Seizure; 2011 Nov; 20(9):667-72. PubMed ID: 21763158 [TBL] [Abstract][Full Text] [Related]
19. Efficacy and tolerability of immediate switch from sodium channel blockers to Lacosamide. Talha Özgün O; Kandemir Yılmaz M; Mert Atmaca M; Keskin Güler S; Buluş E; Duman A; Çelebi Ö; Gürses C Epilepsy Behav; 2023 Aug; 145():109355. PubMed ID: 37473655 [TBL] [Abstract][Full Text] [Related]
20. Lacosamide as first add-on or conversion monotherapy: A retrospective real-life study. Casciato S; Quarato PP; Gialluisi A; D'Aniello A; Mascia A; Grammaldo LG; Di Gennaro G Epilepsy Behav; 2021 Sep; 122():108128. PubMed ID: 34229159 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]